Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study: Metabolism

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study: Metabolism

<strong>Aims</strong> To investigate whether metformin therapy alters amino acid concentrations, increased levels of which have been found to predict Type 2 diabetes. <strong>Methods</strong> In the Carotid Atherosclerosis: Metformin for Insulin Resistance (CAMERA) study (NC...

Full description

Bibliographic Details
Main Authors:	Preiss, D, Rankin, N, Welsh, P, Holman, R, Kangas, A, Soininen, P, Würtz, P, Ala-Korpela, M, Sattar, N
Format:	Journal article
Published:	Wiley 2016

Similar Items

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial
by: Preiss, D, et al.
Published: (2016)

Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial
by: Alramah, T, et al.
Published: (2019)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by: Welsh, P, et al.
Published: (2018)

Putative miRNA biomarkers of insulin resistance and the effect of metformin: data from the CAMERA trial
by: ALRamah, T, et al.
Published: (2017)

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): A randomised controlled trial
by: Preiss, D, et al.
Published: (2014)

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
by: Preiss, D, et al.
Published: (2014)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
by: Preiss, D, et al.
Published: (2016)

Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.
by: Rankin, N, et al.
Published: (2016)

Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation
by: Wang, Q, et al.
Published: (2017)

DHA mediates the protective effect of fish consumption on new episodes of depression among women
by: Reeves, J, et al.
Published: (2017)

A comparison of anthropometric, metabolic and reproductive characteristics of young adult women from opposite-sex and same sex twin pairs
by: Pirkko eKorsoff, et al.
Published: (2014-03-01)

Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet).
by: Maria Lankinen, et al.
Published: (2014-01-01)

Association of pre-pregnancy body mass index with offspring metabolic profile: Analyses of 3 European prospective birth cohorts.
by: Diana L Santos Ferreira, et al.
Published: (2017-08-01)

Risk of anaemia with long-term metformin use in a community setting
by: Donnelly, L, et al.
Published: (2017)

Amino acid homeostasis is a target of metformin therapy
by: Calum Forteath, et al.
Published: (2023-08-01)

A differential network approach to exploring differences between biological states: an application to prediabetes.
by: Beatriz Valcárcel, et al.
Published: (2011-01-01)

An interaction map of circulating metabolites, immune gene networks, and their genetic regulation
by: Artika P. Nath, et al.
Published: (2017-08-01)

Melatonin Potentiates the Therapeutic Effects of Metformin in Women with Metabolic Syndrome
by: Sattar J. Abood, et al.
Published: (2020-06-01)

Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort
by: Elin Org, et al.
Published: (2017-04-01)

Metformin and risk of cardiovascular disease.
by: Turner, R, et al.
Published: (1999)

Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts
by: Emmi Tikkanen, et al.
Published: (2021-12-01)

GDF15 mediates the effects of metformin on body weight and energy balance
by: Coll, A, et al.
Published: (2019)

Metabolic Action of Metformin
by: Izabela Szymczak-Pajor, et al.
Published: (2022-06-01)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.
by: Timo Paavola, et al.
Published: (2017-01-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
by: Holman, R, et al.
Published: (1989)

Metformin in metabolic syndrome treatment
by: V. I. Podzolkov, et al.
Published: (2005-06-01)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
by: Holman, R
Published: (2007)

Low branched chain amino acids and tyrosine in Thai patients with type 2 diabetes mellitus treated with metformin and metformin-sulfonylurea combination therapies
by: Sriboonvorakul, N, et al.
Published: (2021)

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
by: Griffin, SJ, et al.
Published: (2018)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
by: Wright, A, et al.
Published: (1998)

Metformin and mortality. Reply to Lund SS [letter]
by: Stevens, R, et al.
Published: (2013)

Metformin and mortality. Reply to Lund SS [letter].
by: Stevens, R, et al.
Published: (2013)

Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
by: Holmes, M, et al.
Published: (2017)

Siofor (metformin) administration in the treatment of metabolic syndrome in patients with gout in hospital
by: V. B. Maximenko, et al.
Published: (2016-05-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: V. A. Nevzorova, et al.
Published: (2015-12-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: V. A. Nevzorova, et al.
Published: (2015-12-01)

Metformin-regulated glucose flux from the circulation to the intestinal lumen
by: Kazuhiko Sakaguchi, et al.
Published: (2025-03-01)

Effect of metformin on breast cancer metabolism
by: Lord, S, et al.
Published: (2014)

Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing
by: Preiss, D, et al.
Published: (2016)

Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure
by: Preiss, D, et al.
Published: (2016)